Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

20151,661 citationsJournal Article

Authors

Daniela Cardinale · Centro Cardiologico Monzino

Alessandro Colombo · Centro Cardiologico Monzino

Giulia Bacchiani · Centro Cardiologico Monzino

Ines Tedeschi · Centro Cardiologico Monzino

Carlo A. Meroni · Centro Cardiologico Monzino

Fabrizio Veglia · Centro Cardiologico Monzino

Maurizio Civelli

Abstract

Most cardiotoxicity after anthracycline-containing therapy occurs within the first year and is associated with anthracycline dose and LVEF at the end of treatment. Early detection and prompt therapy of cardiotoxicity appear crucial for substantial recovery of cardiac function.

Topics & Keywords

Chemotherapy-induced cardiotoxicity and mitigation Chemotherapy-induced organ toxicity mitigation Cancer Treatment and Pharmacology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

Volume 131, Issue 22, pp. 1981-1988

DOI: 10.1161/circulationaha.114.013777

Field-Weighted Citation Impact: 69.97